152 related articles for article (PubMed ID: 9017662)
1. Further characterisation of [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding sites in human brain postmortem.
Palego L; Marazziti D; Rotondo A; Batistini A; Lucacchini A; Naccarato AG; Bevilacqua G; Borsini F; Ladinsky H; Cassano GB
Neurochem Int; 1997 Feb; 30(2):149-57. PubMed ID: 9017662
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
Hall MD; Gozlan H; Emerit MB; el Mestikawy S; Pichat L; Hamon M
Neurochem Res; 1986 Jun; 11(6):891-912. PubMed ID: 3016581
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the binding of [3H]WAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brain.
Khawaja X; Evans N; Reilly Y; Ennis C; Minchin MC
J Neurochem; 1995 Jun; 64(6):2716-26. PubMed ID: 7760052
[TBL] [Abstract][Full Text] [Related]
4. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Khawaja X; Ennis C; Minchin MC
Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
[TBL] [Abstract][Full Text] [Related]
6. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
Yokota N; Yamawaki S; Hayakawa H; Yoshida R; Sarai K
Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729
[TBL] [Abstract][Full Text] [Related]
7. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
[TBL] [Abstract][Full Text] [Related]
8. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.
Alexander BS; Wood MD
J Pharm Pharmacol; 1988 Dec; 40(12):888-91. PubMed ID: 2907586
[TBL] [Abstract][Full Text] [Related]
9. Metal ion and guanine nucleotide modulations of agonist interaction in G-protein-coupled serotonin1A receptors from bovine hippocampus.
Harikumar KG; Chattopadhyay A
Cell Mol Neurobiol; 1998 Oct; 18(5):535-53. PubMed ID: 9777253
[TBL] [Abstract][Full Text] [Related]
10. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
11. Resolution of multiple affinity states of 5-hydroxytryptamine-1A receptors labelled by [3H]-8-hydroxy-2-(di-n-propilamino) tetralin in rat hippocampal membranes.
Pesce G; Hery F
Gen Pharmacol; 1996 Jun; 27(4):723-9. PubMed ID: 8853311
[TBL] [Abstract][Full Text] [Related]
12. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
Hall MD; el Mestikawy S; Emerit MB; Pichat L; Hamon M; Gozlan H
J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of 3H-agonist binding to pre- and postsynaptic 5-HT1A receptors in bovine brain.
Iben LG; Mahle CD; Yocca FD
Br J Pharmacol; 1994 Dec; 113(4):1400-6. PubMed ID: 7889298
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA
J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
[TBL] [Abstract][Full Text] [Related]
15. Alkylation of [3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus.
Nénonéné EK; Radja F; Carli M; van Gelder NM; Afkhami-Dastjerdian S; Reader TA
Neurochem Res; 1996 Feb; 21(2):167-76. PubMed ID: 9182242
[TBL] [Abstract][Full Text] [Related]
16. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
Emerit MB; Miquel MC; Gozlan H; Hamon M
J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
[TBL] [Abstract][Full Text] [Related]
17. Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues.
Harrington MA; Peroutka SJ
J Neurochem; 1990 Jan; 54(1):294-9. PubMed ID: 2136705
[TBL] [Abstract][Full Text] [Related]
18. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia.
Hashimoto T; Nishino N; Nakai H; Tanaka C
Life Sci; 1991; 48(4):355-63. PubMed ID: 1824956
[TBL] [Abstract][Full Text] [Related]
19. Species differences in regional patterns of 3H-8-OH-DPAT and 3H-zolpidem binding in the rat and human brain.
Duncan GE; Knapp DJ; Breese GR; Crews FT; Little KY
Pharmacol Biochem Behav; 1998 Jun; 60(2):439-48. PubMed ID: 9632227
[TBL] [Abstract][Full Text] [Related]
20. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.
Herrick-Davis K; Titeler M
J Neurochem; 1988 Feb; 50(2):528-33. PubMed ID: 2961850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
